Despite a lack of evidence Duke University is all-in on stem cells for autism, thanks to a billionaire benefactor and a Panama stem cell clinic. This is the dark(er) side of quackademic medicine.
Antivaxers frequently object to the use of fetal cell lines to manufacture vaccines on “moral” grounds. Über-quack Joe Mercola lays down some astonishingly bad moral arguments based on pseudoscience.
Kylee Dixon is a 13-year-old girl with undifferentiated embryonal sarcoma of the liver whose mother stopped chemotherapy and has been treating her with CBD oil. The State of Oregon intervened to see that Kylee undergoes appropriate surgery. Where do “parental rights” end and the child’s rights begin?
The ethics of pay-to-play clinical trials are a minefield. Last week the HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) stepped into that minefield. Are “pay-to-play” clinical trials ever ethically acceptable?
Stem cell therapies show great promise, but as yet the vast majority of that promise has not been validated in rigorous clinical trials. Unfortunately, for-profit stem cell clinics are running clinical trials that require patients to pay to be part of them (“pay-to-play”). These trials are not rigorous. Even more unfortunately, it appears that some universities are also running “pay-to-play” clinical trials that bear an uncomfortable resemblance to those run by for-profit clinics.